ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Irinotecan in Treating Children With Refractory Solid Tumors

This study has been completed.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Neuroblastoma
Sarcoma
2 Additional conditions recognized in this trial
Central Nervous System Neoplasms
Nervous System Neoplasms
3 More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Nervous System Diseases
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive, Peripheral
4 Interventions listed in this trial
irinotecan hydrochloride
5 Additional drug interventions recognized in this trial
Camptothecin
Irinotecan
6 More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
7 Sponsors listed in this trial
Children's Oncology Group
National Cancer Institute (NCI)




Links to all studies - primarily for crawlers